Mainolfi Nello (CIK 0001821189)

Latest company ownership

Shares held
30,000
Last filed at
Oct 29, 2025
Confidence Score
16.3
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 8, 2025 Dec 8, 2025 Kymera Therapeutics, Inc. CEO Sell 18.8 -100,000 -13.15% ✓ $8.9M
Oct 29, 2025 Oct 29, 2025 Kymera Therapeutics, Inc. CEO Sell 32.5 -30,000 -4.34% ✓ $1.8M
Sep 16, 2025 Sep 16, 2025 Kymera Therapeutics, Inc. CEO Sell 32.5 -30,000 -4.34% ✓ $1.5M
Jun 3, 2025 Jun 3, 2025 Kymera Therapeutics, Inc. CEO Sell 32.5 -30,000 -4.34% ✓ $1.5M
Jan 10, 2022 Jan 12, 2022 Kymera Therapeutics, Inc. CEO Sell 42.5 -48,000 -0.91% ✓ $2.6M
Oct 8, 2021 Oct 12, 2021 Kymera Therapeutics, Inc. CEO Sell 40.0 -48,000 -1.26% ✓ $2.7M
Aug 3, 2021 Aug 5, 2021 Kymera Therapeutics, Inc. CEO Sell 45.0 -6,706 -0.74% ✓ $402.8K
Jul 29, 2021 Aug 2, 2021 Kymera Therapeutics, Inc. CEO Sell 40.0 -30,415 -1.33% ✓ $1.8M
Jul 26, 2021 Jul 28, 2021 Kymera Therapeutics, Inc. CEO Sell 42.5 -12,879 -1.40% ✓ $774.6K
Jul 8, 2021 Jul 9, 2021 Kymera Therapeutics, Inc. CEO Sell 23.8 -48,000 -9.60% ✓ $2.4M
Jun 10, 2021 Jun 11, 2021 Kymera Therapeutics, Inc. CEO Sell 27.5 -23,009 -5.29% ✓ $1.2M
Jun 7, 2021 Jun 9, 2021 Kymera Therapeutics, Inc. CEO Sell 42.5 -18,746 -1.49% ✓ $939.3K
May 12, 2021 May 14, 2021 Kymera Therapeutics, Inc. CEO Sell 38.8 -8,245 -2.03% ✓ $412.7K
Apr 22, 2021 Apr 26, 2021 Kymera Therapeutics, Inc. CEO Sell 42.5 -14,407 -1.19% ✓ $579.6K
Apr 15, 2021 Apr 19, 2021 Kymera Therapeutics, Inc. CEO Sell 47.5 -5,593 -0.71% ✓ $225.2K
Apr 8, 2021 Apr 12, 2021 Kymera Therapeutics, Inc. CEO Sell 36.3 -48,000 -2.07% ✓ $1.6M